Research output per year
Research output per year
Search results
-
2024
Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release
Ma, Y., Xie, D., Chen, Z., Shen, X., Wu, X., Ding, F., Ding, S., Pan, Y., Li, F., Lu, A. & Zhang, G., 1 Jul 2024, In: Journal of Translational Medicine. 22, 1, 13 p., 604.Research output: Contribution to journal › Journal article › peer-review
Open Access1 Citation (Scopus) -
Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential
Gubu, A., Ma, Y., Yu, S., Zhang, H., Chen, Z., Ni, S., Abdullah, R., Xiao, H., Zhang, Y., Dai, H., Luo, H., Yu, Y., Wang, L., Jiang, H., Zhang, N., Tian, Y., Li, H., Lu, A., Zhang, B. & Zhang, G., 12 Mar 2024, In: Molecular Therapy Nucleic Acids. 35, 1, 14 p., 102146.Research output: Contribution to journal › Journal article › peer-review
Open Access3 Citations (Scopus) -
2021
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
Ni, S., Zhuo, Z., Pan, Y., Yu, Y., Li, F., Liu, J., Wang, L., Wu, X., Li, D., Wan, Y., Zhang, L., Yang, Z., Zhang, B.-T., Lu, A. & Zhang, G., 3 Mar 2021, In: ACS Applied Materials and Interfaces. 13, 8, p. 9500-9519 20 p.Research output: Contribution to journal › Journal article › peer-review
Open AccessFile356 Citations (Scopus)386 Downloads (Pure)